Aardvark Therapeutics/$AARD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aardvark Therapeutics
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Ticker
$AARD
Sector
Primary listing
Employees
40
Headquarters
Website
AARD Metrics
BasicAdvanced
$77M
-
-$2.93
-
-
Price and volume
Market cap
$77M
52-week high
$17.94
52-week low
$3.35
Average daily volume
387K
Financial strength
Current ratio
10.607
Quick ratio
10.431
Total debt to equity
0.414
Profitability
EBITDA (TTM)
-62.689
Management effectiveness
Return on assets (TTM)
-40.27%
Return on equity (TTM)
-64.44%
Valuation
Price to book
0.73
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-1.284
Free cash flow yield (TTM)
-77.89%
Free cash flow per share (TTM)
-2.765
Growth
Earnings per share change (TTM)
-43.04%
3-year earnings per share growth (CAGR)
-5.57%
AARD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aardvark Therapeutics stock?
Aardvark Therapeutics (AARD) has a market cap of $77M as of March 30, 2026.
What is the P/E ratio for Aardvark Therapeutics stock?
The price to earnings (P/E) ratio for Aardvark Therapeutics (AARD) stock is 0 as of March 30, 2026.
Does Aardvark Therapeutics stock pay dividends?
No, Aardvark Therapeutics (AARD) stock does not pay dividends to its shareholders as of March 30, 2026.
When is the next Aardvark Therapeutics dividend payment date?
Aardvark Therapeutics (AARD) stock does not pay dividends to its shareholders.
What is the beta indicator for Aardvark Therapeutics?
Aardvark Therapeutics (AARD) does not currently have a Beta indicator.